References
- Yasui-Furukori Sato Y, Kato H, Kaneko S. Paroxetine-associated hypereosinophilia may clinically resemble a panic attack. Clin Neuropharmacol. 2012;35(1):47–48.
- Philibert RA, Crowe R, Ryu GY, et al. Transcriptional profiling of lymphoblast lines from subjects with panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(5):674–682.
- Park JE, Kim SW, Park Q, et al. Lymphocyte subsets and mood states in panic disorder patients. J Korean Med Sci. 2005;20(2):215–219.
- Tükel R, Arslan BA, Ertekin BA, et al. Decreased IFN-γ and IL-12 levels in panic disorder. J Psychosom Res. 2012;73(1):63–67.
- Cokmus FP, Özmen E, Alkın T, et al. Evaluation of serum MicroRNA expression profiles in patients with panic disorder. Psychiatry Clin Psychopharmacol. 2018. In Press.
- Bez Y, Ari M, Ozturk OH, et al. Plasma nesfatin-1 level may be associated with disease severity in patients with panic disorder. Klinik Psikofarmakoloji Bülteni. 2010;20(4):288–292.
- Han Almis B, Aksoy I. Mean platelet volume level in patients with generalized anxiety disorder. Psychiatry Clin Psychopharmacol. 2018;28(1):43–47.
- Ayhan MG, Cicek IE, Inanli İ, et al. Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder. Psychiatry Clin Psychopharmacol. 2017;27(3):284–288.
- Uçar HN, Eray Ş, Murat D. Simple peripheral markers for inflammation in adolescents with major depressive disorder. Psychiatry Clin Psychopharmacol. 2018. In Press.
- Klein DF. False suffocation alarms, spontaneous panic and related conditions: an integrative hypothesis. Arch Gen Psychiatry. 1993;50(4):306–317.
- Ross DC, Preter M, Klein DF. Hematologic alterations and CO2 hypersensitivity in male panic disorder patients and normal controls: similarities to high-altitude hypoxia and chronic lung disease. Depress Anxiety. 2001;14(2):153–154.
- Jasnoski M, Bell I, Peterson R. What connections exist between panic symptoms, shyness, type I hypersensitivity, anxiety, and anxiety sensitivity. Anxiety Stress Coping. 1994;7:19–34.
- Rapaport MH. Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers. Biol Psychiatry. 1998;43(6):458–463.
- Atmaca M, Kilic F, Koseoglu F, et al. Neutrophils are decreased in obsessive-compulsive disorder: preliminary investigation. Psychiatry Investig. 2011;8(4):362–365.
- Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive-compulsive disorder. J Clin Psychiatry. 1994;55(suppl.):5–10.
- Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.
- Bandelow B. Assessing the efficacy of treatment for panic disorder and agoraphobia. II. The panic and agoraphobia scale. Int Clin Psychopharmacol. 1995;10(2):73–82.
- Akdemir A, Örsel S, Dağ İ, et al. Hamilton Depresyon Derecelendirme Ölçeği (HDDÖ)’nin geçerliği, güvenirliği ve klinikte kullanımı. 3P Dergisi. 1996;4:251–259.
- Tural Ü, Fidaner H, Alkın T, et al. Panik Agorafobi Ölçeği (PAÖ) Türkçe Uyarlaması. Türk Psikiyatri Dergisi. 2000;11:1.
- Balon R, Rainey JM, Yeragani VK, et al. Hemoglobin and erythrocyte indices in panic disorder. Am J Psychiatry. 1987;144(4):539–540.
- Carr DB, Sheehan DV, Surman OS, et al. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry. 1986;143(4):483–494.
- Kennedy BL, Morris RL, Schwab JJ. Allergy in panic disorder patients: a preliminary report. Gen Hosp Psychiatry. 2002;24(4):265–268.
- Schmidt-Traub S, Bamler K. Psychoimmunologischer zusammenhang zwischen allergien, panik unc agoraphobie. Qeitschrift Klin. Psychol Psychopath Psychother. 1992;40:325–345.
- Kim Y-R, Park Q, Yu B-H. Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder. Psychiatry Res. 2004;128(2):183–190.
- Schleifer SJ, Keller SE, Scott BJ, et al. Lymphocyte function in panic disorder. Biol Psychiatry. 1990;27(9):66.
- Marazziti D, Ambrogi F, Vanacore R, et al. Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology. 1992;26(1–2):23–26.
- Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169:491–497.
- Yoshimura C, Miyamasu M, Nagase H, et al. Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol. 2001;108(2):215–220.